Brought to you by:
New sirolimus data provide encouragement despite ‘potentially disappointing’ efficacy results
The results of a small-scale pilot study from Asia have indicated “potentially disappointing” results with a novel drug-eluting balloon in treating dysfunctional arteriovenous access for dialysis. These findings were delivered by Tjun Tang, MD—who also highlighted “excellent” technical and clinical…
CX 2022: IN.PACT AV DCB shows sustained and superior performance compared to PTA through three years
New randomized controlled data demonstrating the sustained and superior performance of IN.PACT AV drug-coated balloons (DCBs) compared to percutaneous transluminal angioplasty (PTA) through 36 months, with no difference in mortality, was revealed during a Podium 1st presentation at the 2022 Charing…
CX 2022: Overtreatment in venous disease: Financial incentives are ‘the elephant in the room’
To combat the “overtreatment problem” in the appropriate care of venous disease, “a concerted, complex, multimodal effort” is required from specialists across disparate parts of the world. That was the conclusion delivered by Manj Gohel, MD, of Cambridge University Hospitals,…
Nearly 70% of CX 2020 LIVE global aortic audience finds type II endoleak without sac expansion harmless
A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. With registrations now well over 4,000, the pioneering virtual vascular conference continues to attract delegates from far and wide. In this session, presentations, polling and…
CX 2020 LIVE pioneers virtual vascular conference format in COVID-19 era
CX 2020 LIVE came to life online—despite COVID-19—using state-of-the art broadcast technology to bring together more than 1,000 vascular specialists, live, from 95 countries across the world. The first session of the highly interactive conference, designed to deliver global vascular education…
CX 2020 LIVE: Charing Cross Symposium unveils live, interactive digital event
The Charing Cross (CX) Symposium, with its world-class faculty and unique focus on live audience participation, has announced the launch of a not-to-be missed and timely vascular and endovascular education virtual event: CX 2020 LIVE. Mark your calendars for this live…
Global vascular community addresses geographic disparity in COVID-19 impact and response
LONDON—Last week, the Charing Cross (CX) Symposium 2020 would have taken place in the U.K. capital. To mark the occasion virtually, experts from across the globe took part in a wide-ranging, informal chat to share the impact of the COVID-19…